Send me a link:

*Text messaging rates may apply.

 Dow Up 0.05% Nasdaq Up 0.14%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
6.41 Up 0.22(3.55%) 12:32PM EDT - Nasdaq Real Time Price
Prev Close:6.19
Open:6.26
Bid:6.41 x 800
Ask:6.44 x 400
1y Target Est:12.14
Beta:2.94
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:6.10 - 6.50
52wk Range:3.84 - 7.49
Volume:347,261
Avg Vol (3m):398,123
Market Cap:385.99M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNSS

Comparison

Symbol% ChgMkt Cap
SNSSUp 3.55%385.99M
AZNDown 0.05%94.46B
PFEUp 0.20%194.23B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):46.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.72
Quarterly EPS Est (Jun-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback